Enteral Feeding Devices Market

Market Overview

The global enteral feeding devices market size was valued at USD 3.27 billion in 2022. It is projected to reach USD 5.24 billion by 2031, growing at a CAGR of 5.4% during the forecast period (2023-2031). Factors such as growing prevalence of chronic disorders and increase in adoption of enteral feeding in medical conditions, significantly drives the enteral feeding devices market demand by 2031.

Enteral nutrition is a method of administering a balanced diet containing protein, fat, carbohydrates, minerals, and water. This treatment involves the direct delivery of nutrients to the stomach, duodenum, or jejunum. Enteral feeding devices are medical devices used to administer medication and nutrition to chronically ill patients, such as those with malnutrition, gastrointestinal disorders, cancer, and others. These devices are inserted via the nose, mouth, or percutaneous route into the stomach, duodenum, or jejunum. Enteral nutrition can be administered through the use of enteral pumps and enteral feeding tubes. In general, enteral feeding devices are utilized in the operating room (OR), intensive care unit (ICU), and critical care unit (CCU), as well as in the homes of severely ill patients.

Market Dynamics

What are the Primary Factors Driving the Enteral Feeding Devices Market?

Growing Prevalence of Chronic Disorders

Enteral feeding is recommended for patients who are unable to swallow or consume enough nutrients orally. People with cancer, neurological disorders, gastrointestinal disorders, malnutrition, diabetes, and other chronic diseases are unable to swallow or ingest food. As a result, an increase in the number of chronic disease cases is anticipated to drive up enteral nutrition market demand. Furthermore, according to National Cancer Institute data, approximately 1,735,350 new cases of cancer were diagnosed in the United States by the end of 2018. It is estimated that 1.9 million new cancer cases will be diagnosed in the United States in 2021, with 608,570 cancer deaths. Furthermore, the World Health Organization (WHO) reports that cardiovascular disease, cancer, and diabetes were responsible for 17.9 million, 9.0 million, and 1.6 million deaths, respectively. According to American Cancer Society data, approximately 1.8 million new cancer cases will be diagnosed in 2020, with 606,520 cancer deaths occurring in the United States. As a result, the increasing prevalence of chronic diseases will fuel the enteral feeding device market growth.

Growing Adoption of Enteral Feeding in Medical Conditions

Enteral feeding is a treatment involving the direct administration of nutrition or medication to the stomach and intestine. Enteral feeding is one of the most effective methods of delivering nutrients to individuals who cannot meet their nutritional needs at home. The adoption of home enteral feeding has increased over the past few years due to technological advancements, the development of the percutaneous endoscopic gastrostomy (PEG) technique, and a shift in healthcare provision preferences from expensive acute hospitals to home care settings. In addition, enteral nutrition is preferred over parenteral nutrition due to its increased safety and accessibility. In addition, the use of percutaneous jejunostomies, percutaneous dual tube gastrojejunostomies, and nasojejunal tubes has become widespread and is associated with excellent safety. Therefore, enteral feeding is highly acceptable as a home feeding therapy due to its benefits.

What are the Main Factors that will Slow Down the Enteral Feeding Devices Market?

Strict Government Regulations Worldwide

Stringent government regulations for enteral feeding devices are anticipated to limit enteral feeding devices market growth during the analysis period. The government has established stringent and time-consuming guidelines for the approval of medical devices. These feeding tubes must be effective, accurate, and consistent, according to Food and Drug Administration (FDA) guidelines. The regulatory approval process for enteral feeding tubes (Class II) is rigorous and time-consuming. Another disadvantage of the regulatory procedure is the high cost of these trials, which limits product innovation and makes it difficult for small businesses to survive in the market without the support of large corporations.

What are the Future Opportunities for Enteral Feeding Devices Market?

Increasing Technological Advancements

New technologically advanced devices are being introduced to improve the safety and precision of enteral feeding. Researchers and key players create new devices with fewer complications and enhanced efficacy. For instance, the FDA has approved Fidmi Medical's low-profile enteral feeding device. This low-profile enteral feeding device, which is an endoscopically placed percutaneous gastrostomy tube, is comparable to conventional PEG tubes. In addition, market leaders are focusing on the approval and launch of new products in order to expand their product portfolios. For instance, NeoMed, Inc. was granted a U.S. patent for its ENFit Low Dose Tip Syringe. In addition, NeoMed, Inc. introduced NeoConnect at home, a portfolio of reusable ENFit syringes that do not require a doctor's prescription. In light of this, it is anticipated that the enteral feeding devices market demand will increase in the near future.

Regional Analysis

The global enteral feeding devices market share is bifurcated into four regions, namely North America, Europe, Asia-Pacific, and LAMEA.

Europe Dominates the Global Market

Europe region is the highest contributor to the market and is anticipated to grow at a CAGR of 5.1% during the forecast period. The growing number of cancer patients, the aging population, the prevalence of neurological diseases, and the increasing number of surgical procedures are all anticipated to increase the demand for enteral feeding devices to meet their nutritional needs. Furthermore, according to the European Commission's 2020 Ageing Report, nearly one-fifth (19%) of the E.U. population was 65 or older in 2018, with that figure anticipated to rise to nearly 51.2% by 2070. As a result, a large patient pool is anticipated to increase the demand for enteral feeding products used during enteral nutrition. Furthermore, early approval of enteral feeding devices and widespread adoption of enteral feeding pumps in this region are driving the market growth.

North America is anticipated to witness dynamic growth in the global market, with a CAGR of 4.95% during the forecast period. Cancer is one of the most common and widespread diseases in North America, affecting millions of people. According to data from the United States Department of Health and Human Services, approximately 1,735,350 new cases of cancer will be diagnosed in the United States in 2020. As a result of the large number of people diagnosed with cancer, the demand for enteral nutrition required during cancer diagnosis will increase, fueling the enteral feeding devices market. The global market in North America is driven by factors such as an increase in the geriatric population, a preference for home-based enteral feeding, and the adoption of enteral feeding pumps.

Asia-Pacific is anticipated to witness a significant CAGR of 6.17% in the enteral feeding devices industry during the forecast period because of increased affordability, increased healthcare spending, and increased awareness of the benefits of safe enteral feeding. Asia-Pacific, which is anticipated to grow the fastest during the forecast period, offers lucrative opportunities in the enteral feeding devices market. The Asia-Pacific region is densely populated, with India and China being the most populous. Its expansion is aided by an increase in demand for enteral feeding products, a large number of healthcare reforms, a high prevalence of several chronic conditions, and a greater focus on the development of technologically advanced, cost-effective, and safe products such as enteral feeding pumps by key players. With 3,519,100 preterm births or more than 24% of the total number, India ranks first among the ten countries that contribute 60% of the world's premature births, according to the most recent data from Newborn & Child Health and the World Health Organization. Babies born prematurely face long-term health issues such as cerebral palsy, poor growth, and starvation. These negative events, combined with an increase in chronic diseases, are anticipated to increase the country's use of enteral feeding devices.

The LAMEA region is anticipated to witness a moderate CAGR of 5.8% in the global enteral feeding devices industry during the forecast period. Increased government funding and the development of programs to raise awareness about enteral nutrition, as well as the entry of key players, are anticipated to drive the global market in this region. Brazil is the world's fifth-largest country in terms of both size and population. According to data from the Organization for Economic Cooperation and Development (OECD), Brazil's elderly population is growing at a faster rate.

Segmental Analysis

The global enteral feeding devices market is segmented by product, age group, end user, and application.

Based on product, the global market is bifurcated into enteral feeding pumps, enteral syringes, giving sets, enteral feeding tubes, and consumables.

The enteral feeding pumps segment is the highest contributor to the market and is anticipated to grow at a CAGR of 6.2% during the forecast period. Enteral feeding pumps are electronic medical devices that are used to deliver feeds, nutrients, water, or medications to patients while they are undergoing enteral feeding. Microprocessor controls, screen displays for programming options, an alarm, automatic tube flush, a delivery set security door, and anti-free-flow protection is all included in enteral feeding pumps. These devices are portable and easy to transport. The increased use of enteral nutrition in hospitals and the home sector has raised concerns about the safety of enteral nutrition delivery. As a result, enteral feed pumps are widely used by patients, mostly at home, to ensure their safety.

The enteral feeding tube segment is anticipated to witness a higher CAGR of 5.9%. Enteral feeding tubes are medical devices used to provide nutrition or feed people who cannot obtain nutrition through their mouth, cannot swallow safely, or require nutritional supplements. Increased prevalence of esophageal and stomach cancer, as well as swallowing disorders, increase the use of feeding tubes. Furthermore, an increase in the number of patients admitted to a hospital ICU increases the use of enteral feeding tubes.

Based on the age group, the global market is bifurcated into adults and pediatrics.

The adult segment is the highest contributor to the enteral feeding devices market share and is anticipated to grow at a CAGR of 5.05% during the forecast period. Adults who require enteral feeding typically have swallowing disorders, throat cancer, head and neck cancer, various gastrointestinal disorders, diabetes, and other conditions. Adults can survive on tube feeding for as long as they need to. Adults who are malnourished require enteral nutrition as well.

The pediatrics segment is anticipated to grow at a significant CAGR of 6.2%. Pediatric patients typically necessitate special attention and have a number of requirements for proper growth and development. Enteral feeding is the administration of nutrients directly into the stomach, duodenum, or jejunum via a tube or stoma. Enteral feeding is recommended for children who are unable to consume enough food, have maldigestion and malabsorption (nutritional losses), such as those with short bowel syndrome, chronic diarrhea of infancy, Crohn's disease, inborn errors, impaired organ function, and variety of other conditions. In pediatrics, the stomach is preferred over the nose or the oral route for nutrient delivery.

Based on end users, the global market is bifurcated into hospitals, ambulatory surgical centers, and home care.

The hospital segment is the highest contributor to the market and is anticipated to grow at a CAGR of 5.3% during the forecast period. Hospitals are healthcare facilities that house specialized medical and nursing staff as well as specialized medical equipment. In hospitals, enteral feeding is commonly used to provide nutrition, feeds, and medications to patients. The use of enteral feeding devices to deliver specific medications is permitted in hospitals to treat a variety of conditions. Furthermore, the enteral tube feeding should be reviewed on a regular basis to allow for the reintroduction of oral nutrition when necessary, which hospital staff can easily do.

The home care segment is anticipated to grow at a significant CAGR of 6.15%. The introduction of home care-based enteral feeding devices enables patients to receive regular nutrition-feeding treatments in the comfort of their own homes. Home-based enteral feeding devices, such as pumps, reduce the number of clinics or hospital visits for enteral nutrition. Home care enteral nutrition therapies include the administration of feeds such as protein, carbohydrates, growth factors, and nutrition. Furthermore, home care enteral feeding entails regular patient monitoring as well as blood panels and another testing that may be required during treatment. As a result, the patient's hospital stay is reduced, and lifestyle activities can resume more quickly.

Based on application, the global market is bifurcated into gastrointestinal diseases, cancer, malnutrition, neurological disorders, and others.

The neurological disorders segment is the highest contributor to the market and is anticipated to grow at a CAGR of 5.3% during the forecast period. Neurological disorders are health conditions that affect the nervous system. Paralysis, poor coordination, seizures, confusion, pain, and altered levels of consciousness are all symptoms of neurological disorders. Epilepsy, Alzheimer's disease, other dementias, Parkinson's disease, brain tumors, and other conditions are examples of these disorders. People with various types of neurological disorders are at risk of malnutrition in addition to dysphagia. Furthermore, central nervous system injury causes significant complications that affect patients' nutritional status, eventually leading to malnutrition. Nutritional support is thus an important adjunctive therapy for chronic neurological patients.

The cancer segment is anticipated to grow at a significant CAGR of 5.9%. Because cancer patients are unable to eat properly, enteral feeding devices are used to deliver nutrients via tube. The large number of new cancer cases reported is one of the factors driving the global market for cancer. Furthermore, enteral nutrition is preferred over parenteral nutrition because parenteral nutrition cannot be used for prolonged nutrient delivery and is associated with numerous complications. Enteral feeding tubes are used in a variety of cancer cases to deliver nutrients and feeds to cancer patients. As a result, the cancer segment is subdivided into head and neck cancers, gastrointestinal cancers, liver cancer, pancreatic cancer, esophageal cancer, and others.

Recent Developments

• February 2022, ALCOR Scientific Inc partnered with Water Street to propel the expansion of its product portfolio and increase its global reach.
• April 2022, Abbott Nutrition ramps up the production of infant formula to meet the rising demand in the USA.